$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

$kavl Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000173112223000408 Filed on March 17, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q1
Revenue	$2.526M	$3.012M	$2.842M
YoY Change	-11.12%	-94.88%	-92.39%
Cost Of Revenue	$1.986M	$1.910M	$3.533M
YoY Change	-43.79%	-95.92%	-89.15%
Gross Profit	$540.1K	$1.102M	-$690.9K
YoY Change	-178.17%	-90.76%	-114.39%
Gross Profit Margin	21.38%	36.59%	-24.31%
Selling, General & Admin	$3.547M	$3.834M	$2.091M
YoY Change	69.63%	-82.89%	-52.26%
% of Gross Profit	656.7%	347.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$116.00		$0.00
YoY Change
% of Gross Profit	0.02%
Operating Expenses	$3.547M	$3.834M	$2.091M
YoY Change	69.63%	-82.89%	-52.15%
Operating Profit	-$3.007M	-$2.732M	-$2.782M
YoY Change	8.08%	-73.91%	-746.97%
Interest Expense	$11.95K	$0.00	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	$11.95K
YoY Change
Pretax Income	-$2.995M	-$2.732M	-$2.782M
YoY Change	7.65%	-73.91%	-762.37%
Income Tax		-$12.51K	$0.00
% Of Pretax Income
Net Earnings	-$2.995M	-$2.719M	-$2.782M
YoY Change	7.65%	-69.9%	-997.41%
Net Earnings / Revenue	-118.57%	-90.27%	-97.89%
Basic Earnings Per Share	-$1.12
Diluted Earnings Per Share	-$0.05	-$0.05	-$92.01K
COMMON SHARES
Basic Shares Outstanding	56.17M shares
Diluted Shares Outstanding	2.675M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.774M	$3.686M	$5.590M
YoY Change	-32.5%	-52.5%	185.23%
Cash & Equivalents	$3.774M	$3.686M	$5.656M
Short-Term Investments
Other Short-Term Assets	$316.6K	$426.4K	$355.5K
YoY Change	-10.94%	10.89%
Inventory	$3.761M	$1.240M	$14.77M
Prepaid Expenses	$316.6K	$426.4K
Receivables	$518.3K	$574.6K	$1.296M
Other Receivables	$2.026M	$1.539M	$1.754M
Total Short-Term Assets	$10.40M	$9.073M	$23.76M
YoY Change	-56.25%	-69.89%	62.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.155M	$1.199M	$51.96K
YoY Change	2123.6%	2056.42%	-25.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.364K
YoY Change
Total Long-Term Assets	$2.639M	$3.364M	$51.95K
YoY Change	4979.27%	5949.67%	-13.42%
TOTAL ASSETS
Total Short-Term Assets	$10.40M	$9.073M	$23.76M
Total Long-Term Assets	$2.639M	$3.364M	$51.95K
Total Assets	$13.03M	$12.44M	$23.81M
YoY Change	-45.26%	-58.8%	61.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$81.27K	$40.02K	$9.310M
YoY Change	-99.13%	-99.69%	48.96%
Accrued Expenses	$675.5K	$1.099M	$387.8K
YoY Change	74.19%	85.47%	-66.86%
Deferred Revenue	$12.10K	$44.97K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.787M	$1.585M	$9.845M
YoY Change	-61.54%	-88.53%	11.12%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.006M	$1.051M	$42.69K
YoY Change	2257.55%	2174.91%	-28.85%
Total Long-Term Liabilities	$1.006M	$1.051M	$42.69K
YoY Change	2257.55%	2174.91%	-28.85%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.787M	$1.585M	$9.845M
Total Long-Term Liabilities	$1.006M	$1.051M	$42.69K
Total Liabilities	$4.793M	$2.636M	$9.888M
YoY Change	-51.52%	-80.99%	10.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.63M	-$19.63M
YoY Change		273.16%
Common Stock	$56.17K	$56.17K
YoY Change		86.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.242M	$9.801M	$13.93M
YoY Change
Total Liabilities & Shareholders Equity	$13.03M	$12.44M	$23.81M
YoY Change	-45.26%	-58.8%	61.78%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q1
OPERATING ACTIVITIES
Net Income	-$2.995M	-$2.719M	-$2.782M
YoY Change	7.65%	-69.9%	-997.41%
Depreciation, Depletion And Amortization	$116.00		$0.00
YoY Change
Cash From Operating Activities	$91.22K	$274.1K	-$2.134M
YoY Change	-104.28%	-109.04%	-60.71%
INVESTING ACTIVITIES
Capital Expenditures	$3.480K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.480K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$35.76K
YoY Change			19.2%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		53.72K	-35.76K
YoY Change		-99.46%	19.2%
NET CHANGE
Cash From Operating Activities	$91.22K	274.1K	-2.134M
Cash From Investing Activities	-$3.480K
Cash From Financing Activities		53.72K	-35.76K
Net Change In Cash	$87.74K	327.8K	-2.169M
YoY Change	-104.04%	-95.24%	-60.27%
FREE CASH FLOW
Cash From Operating Activities	$91.22K	$274.1K	-$2.134M
Capital Expenditures	$3.480K
Free Cash Flow	$87.74K		-$2.134M
YoY Change	-104.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3202265	shares
CY2022Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2022Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable		usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2022Q1	kavl	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	kavl	Royalty Revenue RoyaltyRevenue		usd
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue		usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet		usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense		usd
CY2022Q1	us-gaap	Depreciation Depreciation		usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001762239
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	kavl	Settled Rsus With Cash SettledRsusWithCash		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q1	kavl	Aggregate Exercise Price Exercised AggregateExercisePriceExercised		usd
CY2023Q1	kavl	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercised Options Weighted Average Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2023Q1	kavl	Aggregate Exercise Price Cancelled Forfeited Or Expired AggregateExercisePriceCancelledForfeitedOrExpired		usd
CY2023Q1	kavl	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Cancelled Forfeited Or Expired Options Weighted Average Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeCancelledForfeitedOrExpiredOptionsWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-01-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-56016
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	KAIVAL BRANDS INNOVATIONS GROUP, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-3492907
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4460 Old Dixie Highway
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Grant-Valkaria
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32949
CY2023Q1	dei	City Area Code CityAreaCode	(833)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	452-4825
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	KAVL
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56169090	shares
CY2023Q1	us-gaap	Cash Cash	3773628	usd
CY2022Q4	us-gaap	Cash Cash	3685893	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	518291	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	574606	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	2026245	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1539486	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3761491	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1239725	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	316621	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	426407	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	1607302	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	10396276	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9073419	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3364	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	1483297	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	2164646	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1152020	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1198969	usd
CY2023Q1	us-gaap	Assets Assets	13034957	usd
CY2022Q4	us-gaap	Assets Assets	12437034	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	81265	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	40023	usd
CY2023Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2350787	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	675453	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1099157	usd
CY2023Q1	us-gaap	Deposit Liability Current DepositLiabilityCurrent	12098	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	44973	usd
CY2023Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	366956	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	0	usd
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	129702	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	235274	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170603	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166051	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3786864	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1585478	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1006435	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1050776	usd
CY2023Q1	us-gaap	Liabilities Liabilities	4793299	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2636254	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56169090	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56169090	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56169090	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56169090	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	56169	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	56169	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	30811574	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29375787	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22626085	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19631176	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8241658	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9800780	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13034957	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12437034	usd
CY2023Q1	kavl	Revenue Revenue	2435835	usd
CY2022Q1	kavl	Revenue Revenue	2841990	usd
CY2023Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	3085	usd
CY2022Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	23765	usd
CY2023Q1	kavl	Royalty Revenue RoyaltyRevenue	105572	usd
CY2023Q1	kavl	Excise Tax On Products ExciseTaxOnProducts	18574	usd
CY2022Q1	kavl	Excise Tax On Products ExciseTaxOnProducts	23872	usd
CY2023Q1	us-gaap	Revenues Revenues	2525918	usd
CY2022Q1	us-gaap	Revenues Revenues	2841883	usd
CY2023Q1	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	1985800	usd
CY2022Q1	kavl	Cost Of Revenue Related Party CostOfRevenueRelatedParty	3484620	usd
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	48172	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1985800	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3532792	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	540118	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-690909	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	588910	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	592501	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2958069	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1498554	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	3546979	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2091055	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	11952	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11952	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2994909	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2781964	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2994909	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2781964	usd
CY2023Q1	kavl	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.05
CY2022Q1	kavl	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-0.09
CY2023Q1	kavl	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	56169090	shares
CY2022Q1	kavl	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	30234477	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9800780	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1435787	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-2994909	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	8241658	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16324313	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	110250	usd
CY2022Q1	kavl	Common Shares Settled And Cancelled CommonSharesSettledAndCancelled	-35759	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	309700	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-2781964	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	13926540	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2994909	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2781964	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	110250	usd
CY2023Q1	us-gaap	Depreciation Depreciation	116	usd
CY2023Q1	kavl	Stock Option Plan Expenses StockOptionPlanExpenses	1435787	usd
CY2022Q1	kavl	Stock Option Plan Expenses StockOptionPlanExpenses	309700	usd
CY2023Q1	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	46949	usd
CY2022Q1	kavl	Rou Operating Lease Expense RouOperatingLeaseExpense	3649	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-56315	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-688982	usd
CY2023Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-194590	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-109786	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-29543	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2521766	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3484620	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1607302	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	41242	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62812	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2350787	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-3538010	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-423704	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-205192	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-105572	usd
CY2023Q1	kavl	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-32875	usd
CY2023Q1	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	-366956	usd
CY2022Q1	kavl	Increase Decrease In Customer Refund Due IncreaseDecreaseInCustomerRefundDue	169110	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-39789	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3170	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	91215	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2133514	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3480	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3480	usd
CY2022Q1	kavl	Settled Rsus With Cash SettledRsusWithCash	35759	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-35759	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	87735	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2169273	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3685893	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7825235	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3773628	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5655962	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	106385	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zTlxyR1Rs9K2" style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"><b><span id="xdx_86A_z21HcXilhkTd">Use of Estimates</span></b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3773628	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3685893	usd
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3250651	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2912793	usd
CY2021Q4	us-gaap	Description Of Lessee Leasing Arrangements Operating Leases DescriptionOfLesseeLeasingArrangementsOperatingLeases	the Company entered into a month- to-month lease agreement with FFE Solutions Group, located in Salt Lake City Utah, to store additional product inventory at this satellite location. The Company made payments on this lease in the amount of $19,108. This lease was terminated in April 2022.
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2023Q1	kavl	Reverse Stock Split Description ReverseStockSplitDescription	as a result of the Reverse Stock Split, the conversion rate was adjusted such that each share of the Series A Preferred Stock is convertible into approximately 8.33 shares of Common Stock.
CY2023Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	3000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12098	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	44973	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	129701	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	235274	usd
CY2023Q1	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	366956	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	0	usd
CY2023Q1	kavl	Revenue From Sale RevenueFromSale	432000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1287180	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P10Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.7568	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0412	pure
CY2023Q1	kavl	Working Capital WorkingCapital	6503841	usd
CY2021Q4	us-gaap	Description Of Lessee Leasing Arrangements Operating Leases DescriptionOfLesseeLeasingArrangementsOperatingLeases	the Company entered into a month-to-month lease agreement with Ranger Enterprises, LLC, located in Seymour, Indiana, to store product inventory at this satellite location. The Company made payments on this lease in the amount of $19,959. The lease was terminated in June 2022.
CY2023Q1	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	-46949	usd
CY2022Q1	us-gaap	Proceeds From Lease Payments ProceedsFromLeasePayments	-3649	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1152020	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1198969	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	170603	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	166051	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1006435	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1050776	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1177038	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1216827	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	164139	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	228134	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	238800	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	253614	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	450934	usd
CY2023Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1335621	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	158583	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1177038	usd
CY2023Q1	kavl	Additional Leases AdditionalLeases	0	usd
CY2023Q1	kavl	Common Stock Share Issued CommonStockShareIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	kavl	Aggregate Exercise Price Outstanding AggregateExercisePriceOutstanding	8921419	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.79
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3250000	shares
CY2023Q1	kavl	Aggregate Exercise Price Granted AggregateExercisePriceGranted	3207425	usd
CY2023Q1	kavl	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Weighted Average Exercise Price SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice	0.99
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.99
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6452265	shares
CY2023Q1	kavl	Aggregate Exercise Price Outstanding AggregateExercisePriceOutstanding	12128844	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.88
CY2023Q1	kavl	Unrecognized Expenses Related To Options UnrecognizedExpensesRelatedToOptions	3488735	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P9Y4M17D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q1	kavl	Inventory Quality Control Expenses InventoryQualityControlExpenses	3697210	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	347760	usd
CY2023Q1	kavl	Service Agreement Description ServiceAgreementDescription	(i) payment of $125,000 per month; (ii) bonus equivalent to 0.27% of the applicable gross quarterly sales and (iii) a grant of 3,000,000 nonqualified stock options to purchase shares of Company common stock which shall vest based on achievement of certain net revenue and profit margin targets up to $180,000,000 in total net revenues over a period of 3 years
CY2023Q1	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	28318	usd
CY2022Q1	us-gaap	Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome	33871	usd

Files In Submission

Name	View Source	Status
0001731122-23-000408-index-headers.html	Edgar Link	pending
0001731122-23-000408-index.html	Edgar Link	pending
0001731122-23-000408.txt	Edgar Link	pending
0001731122-23-000408-xbrl.zip	Edgar Link	pending
e4478_10q.htm	Edgar Link	pending
e4478_ex31-1.htm	Edgar Link	pending
e4478_ex31-2.htm	Edgar Link	pending
e4478_ex32-1.htm	Edgar Link	pending
e4478_ex32-2.htm	Edgar Link	pending
e4478_ex33-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.gif	Edgar Link	pending
kavl-20230131.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kavl-20230131_cal.xml	Edgar Link	unprocessable
kavl-20230131_def.xml	Edgar Link	unprocessable
kavl-20230131_lab.xml	Edgar Link	unprocessable
kavl-20230131_pre.xml	Edgar Link	unprocessable
e4478_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl

2023 Q1 Form 10-Q Financial Statement

#000173112223000408 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL Kaival Brands Innovations Group, Inc. Stock $kavl

2023 Q1 Form 10-Q Financial Statement

#000173112223000408 Filed on March 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KAVL
Kaival Brands Innovations Group, Inc. Stock $kavl